4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-006736
Chief Executive Officer gave up 1,759 shares (to pay taxes)
- Chief Executive Officer acquired 6,002 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-03-04 | Option exercise | +6,002 | 64,850 | D: show line 1 in the form | ||
| Robinson Chandler Chief Executive Officer | 2025-03-04 | Shares withheld for taxes | −1,759 | $31.70 | $55,760 | 63,091 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2025-03-04 | Grant or award · Stock Options | +85,759 | 85,759 | D: show line 3 in the form | ||
| Robinson Chandler Chief Executive Officer | 2025-03-04 | Grant or award · Restricted Stock Units | +79,899 | 104,777 | D: show line 4 in the form | ||
| Robinson Chandler Chief Executive Officer | 2025-03-04 | Option exercise · Restricted Stock Units | −6,002 | 98,775 | D: show line 5 in the form |
Loading xslF345X05/rdgdoc.xml…